Literature DB >> 2197371

Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection.

J J Anderson1, J Norden, D Saunders, G L Toms, R Scott.   

Abstract

Pulmonary A2 strain respiratory syncytial virus infection of BALB/c laboratory mice persisted for up to 7 days after initial infection with peak virus titres being recovered on day 4. Virus antigen within the lungs was found to be restricted essentially to the alveolar regions. Similarly, pulmonary histopathological changes remained confined to the peri-alveolar regions being consistent with mild pneumonia. Infection was found to elicit a pulmonary major histocompatibility complex-restricted cytotoxic T lymphocyte (CTL) response which was first detectable 6 days after infection and optimal 7 to 9 days after infection. This local CTL response was preceded by a rapid transient virus-specific lymphocyte transformation response which was detectable only 3 days after intranasal infection. In addition, infection induced rapid interferon production within the lungs which was accompanied by an equally rapid rise in pulmonary natural killer (NK) cell cytotoxic activity. Enhanced NK cell cytotoxicity could be detected after only 1 day post-infection and continued to rise to maximum levels on day 3. This response like the acute CTL response was found to be restricted to the lower respiratory tract. IgG was the first class of virus-specific immunoglobulin to be detected in the lungs of infected animals after experimental infection. However, IgG was not detected until day 10 post-infection, 5 days after the initial decline of virus shedding. Virus-specific IgA although detectable did not appear in the lung until day 24.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197371     DOI: 10.1099/0022-1317-71-7-1561

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  27 in total

1.  The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.

Authors:  Mei Ling Xu; Hyoung Jin Kim; Ga Ram Wi; Hong-Jin Kim
Journal:  J Microbiol       Date:  2015-08-27       Impact factor: 3.422

2.  Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.

Authors:  J Schwarze; E Hamelmann; K L Bradley; K Takeda; E W Gelfand
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response.

Authors:  Alexander Kotelkin; Igor M Belyakov; Lijuan Yang; Jay A Berzofsky; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.

Authors:  A Bukreyev; I M Belyakov; J A Berzofsky; B R Murphy; P L Collins
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.

Authors:  Alexander Bukreyev; Igor M Belyakov; Gregory A Prince; Kevin C Yim; Katie K Harris; Jay A Berzofsky; Peter L Collins
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Host transcription profiles upon primary respiratory syncytial virus infection.

Authors:  Riny Janssen; Jeroen Pennings; Hennie Hodemaekers; Annemarie Buisman; Marijke van Oosten; Lia de Rond; Kemal Oztürk; Jan Dormans; Tjeerd Kimman; Barbara Hoebee
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.

Authors:  A B Kulkarni; H C Morse; J R Bennink; J W Yewdell; B R Murphy
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells.

Authors:  W H Alwan; F M Record; P J Openshaw
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

9.  Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Authors:  Martin L Moore; Michael H Chi; Kasia Goleniewska; Joan E Durbin; R Stokes Peebles
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

10.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.